Volume 14,Issue 3,2022 Table of Contents

  • Display Type:
  • Text List
  • Abstract List
  • 1  Traditional Mongolian medicine: Past, present and future
    Laxinamujila Bai Minghai Fu
    2022, 14(3).
    [Abstract](785) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Traditional Mongolian medicine (TMM) forms an essential part of traditional Chinese medicine (TCM) with its own unique and profound theoretical system, drug resources, processing technologies, and drug usage procedures. TMM has the characteristics of being "raw, simple, inexpensive, and green". It has unique advantages and remarkable efficacy in treating common diseases, frequently-occurring diseases, and certain rare diseases. TMM has been increasingly recognized in recent years, together with an increased understanding and appreciation of its advantages. The development of the TMM industry can not only meet the health needs of local people but also had great significance for the economic and social development of ethnic minority areas. ? Mongolian ancestors not only accumulated healthcare experience compatible with the geographical environment, climate conditions, and way of life but also developed distinctive diets, medicines, and other treatments. According to historical records, the Mongolians had a proficient knowledge of medicine at least 2000 years ago. The Secret History of Mongolia is a literary masterpiece, containing information on medicinal herbs, such as Pyrus betulaefolia, cypress, red artemisia, Sanguisorba?officinalis, Tephroseris kirilowii, mountain leek, and wild onion, amongst many others. In addition, Mongolians make good use of animal medicines, which is inseparable from the production and lifestyle of hunting and husbandry. For example, wild boar dung, fox lung, wolf stomach, bear bile, musk, vulture dung, bat meat, and deer antlers have been used as valuable medicinal materials up to the present day. The TCM theoretical system significantly influenced and promoted the development of TMM medical theory. In addition, with the spread of Buddhism, ancient Indian and Tibetan medical works were also introduced into Mongolia, including the Astanga Hrdaya Samhitd (Eight Branches of Medical Classics) and the Four Medical Tantra, which had a significant influence on the TMM theoretical system during the 16th century. Furthermore, since the founding of the People’s Republic of China, nearly 100 ancient Mongolian medical books have been re-edited and published, and around 2200 Mongolian medicinal herbs and prescriptions have been summarized. This indicates an unprecedented development in TMM under the support of the government. At present, there are increasing numbers of evidence-based investigations into TMM. A variety of studies have been conducted to improve the quality and safety of TMM by optimizing the harvesting time, processing, preparation, and storage of Mongolian medicinal materials. With the development of modern pharmaceutical science, researchers are putting their efforts into the extraction and isolation of active compounds, pharmacology research, the formulation of quality standards, and dosages. Research on the chemical components of the TMM has developed rapidly. Modern chromatographic separation techniques, spectral analysis, and other technologies have been used to isolate and identify the chemical components of the TMM. The quality standard of Guanxin Shutong Capsule, a Mongolian medicine-based new drug was included in Chinese Pharmacopoeia. The application of the internet and big data-mining technology has been used for further improving the quality standards of TMM medicinal materials, using controlled conditions and processing, together with accurate descriptions of the functions and indications. However, there are still many challenges in the TMM field. First, the basic research into TMM has often been relatively weak, with less emphasis on innovative research and the development of new products. This affects the standardization, modernization, and industrialization of TMM significantly. For example, research into the formation of a complete set of quality standards and specifications, including the standardization, material basis, mechanisms of action, and compound preparations is still insufficient. Second, enterprises dealing in Mongolian medicine tend to have low production levels with weak innovation and development capacities. The cooperation between enterprises and universities and research institutions is relatively poor, and scientific research and production cannot be effectively combined. The production process of Mongolian medicine tends to be primitive, using mostly traditional forms of dosage, and many of the preparations lack the attributes of modern pharmaceutical products, such as quick-acting, long-lasting, and sustained-release properties. Last but not least, Mongolian medicine is deficient in wild resources and artificial planting technology has tended to lag. For a long time, Mongolian medicinal materials were largely obtained from the wild, with few planted artificially. With the increasing demand for the raw materials of Mongolian medicine, the output and reserves of wild medicinal materials are declining rapidly, and many medicinal plants are on the verge of extinction. However, there is little research into the artificial cultivation of Mongolian medicinal materials, and the present limited cultivation cannot meet the needs of TMM production, thus threatening the sustainable development of the TMM industry. It is thus important to focus on the combination of modern medicine and traditional Mongolian theory, giving full play to the advantages of the unique characteristics of TMM, and using modern science and technology for Mongolian pharmaceutical industry production and process standardization, quality control, drug standardization, standardization of clinical evaluation, accelerate the realization of the process of transforming TMM research achievements into productivity. At the same time, we should aim to develop a new generation of high-efficiency and low-toxicity pharmaceutical products that are in line with international standards, improve the level of Mongolian medicine research and the development of engineering technology to ensure the quality of TMM preparations, and cultivate more senior engineering and technical personnel. We firmly believe that with the implementation of the “Healthy China” strategy, the advantages of TMM will be further demonstrated and will make greater contributions to human health.
    2  Mongolian medicine: History, development and existing problems
    Songbo Qua Jinshan Baob Wuliji Aob Laxinamujila Baib Almaz Borjigidaia b
    2022, 14(3).
    [Abstract](923) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Mongolian medicine (MM) is an important part of Mongolian culture. Exploration of MM can play a crucial role in the prevention and treatment of various diseases and can help provide better health care globally. In this article, we gave a brief introduction to the origin and development of MM, the theoretical system of MM, the principles of Mongolian materia medica formula, the modern research on Mongolian materia medica and the quality control of Mongolian materia medica. The present situation and outlook of MM were also discussed.
    3  Connotation and scientific research points of processing of Mongolian medicinal materials
    Lin Song Chula Sa Li Mei Lina Du Sarula Wu Rigugaqiqige Su Ligema Dao
    2022, 14(3).
    [Abstract](860) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Traditional Mongolian medicine (TMM) is an important part of Chinese traditional culture, which plays an important role within the medical system of China. The processing of Mongolian medicinal materials is a pharmaceutical technology, which is the unique characteristics of Mongolian medicine. In this paper, the basic concepts related to the processing of Mongolian medicinal materials were introduced, and its scientific research points were put forward, in order to deeply excavate the connotation of Mongolian pharmacy and further study the processing mechanism of Mongolian medicinal materials, so as to provide important basis for the development of Chinese traditional medicine. The essence of Mongolian medicinal materials processing is to use drugs safely and dialectically to ensure the quality of Mongolian medicinal materials. The scientific research sites of Mongolian medicinal materials processing have two categories: reducing toxicity (increasing) effect and synergistic effect of excipients and processing factors. Because of the not perfect research platform of Mongolian medicinal materials and the weak processing power, the development of research of Mongolian medicinal materials is relatively slow. Therefore, there are many research breakthroughs in the interdisciplinary research on the processing of Mongolian medicinal materials, and it is expected to become a research hotspot.
    4  Discussion on evolution of Mongolian medicinal material names and countermeasures for standardization
    Bao Longa Aodungerilea b Laxinamujila Baia b
    2022, 14(3).
    [Abstract](826) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Mongolian pharmacy is an important part of traditional medicine for the Chinese nation, with a long history and a complete theoretical system. The Mongolian people have accumulated and summarized the types and usage of Mongolian medicines in the practice of fighting against diseases over a long history. Mongolian medicinal resources are rich and diverse, the processing is self-contained, and the methods of medication are scientific and reasonable. Mongolian pharmacy not only has a deep historical relationship with traditional Chinese medicine but has also absorbed the essence of ancient Tibetan and Indian Ayurvedic medicine in the process of its development. We can identify the historical traces of the continuous exchange, communication, and integration of various ethnic medicinal cultures from the names of Mongolian medicinal materials. Because of the differences in languages and cultures of the various ethnic groups, the names of Mongolian medicinal materials have undergone a long historical period of evolution. These need to be further standardized owing to complications caused by the existence of synonyms and homonyms.
    5  Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-??B pathway activation
    Shuyin Baoa b d Xiuzhi Wang c Qianqian Ma a b Chengxi Weia b Jixing Nan d Wuliji Ao e f
    2022, 14(3).
    [Abstract](892) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) are the most problematic metabolic diseases in the world. NAFLD encompasses a spectrum of severity, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and fibrosis, increasing the risk of cirrhosis and hepatocellular carcinoma. Importantly, NAFLD is closely linked to obesity and tightly interrelated with insulin resistance and T2DM. T2DM and NAFLD (T2DM-NAFLD) are called as the Xike Rixijing Disease and Tonglaga Indigestion Disease respectively, in Mongolian medicine. Xike Rixijing Disease maybe develop into Tonglaga Indigestion Disease. Forturnately many Mongolian medicines show efficient treatment of T2DM-NAFLD, such as Agriophyllum squarrosum, Haliyasu (dried powder of camel placenta), Digeda-4 (herbs of Lomatogonium carinthiacum, rhizomata of Coptis chinensis, ripe fruits of Gardenia jasminoides, herbs of Dianthus superbus), Guangmingyan Siwei Decoction Powder (Halite, ripe fruits of Terminalia chebula, rhizomata of Zingiber officinale, fruit clusters of Piper longum), Tonglaga-5 (ripe fruits of Punica granatum, barks of Cinnamomum cassia, ripe fruits of Amomum kravanh, fruit clusters of Piperlonguml., flowers of Carthamus tinctorius), Tegexidegeqi (rhizomata of Inula helenium, ripe fruits of Gardenia jasminoides, rhizomata of Platycodon grandiflorum, rhizomata of Coptis chinensis, heartwood of Caesalpinia sappan), Ligan Shiliu Bawei San (ripe fruits of Punica granatum, barks of Cinnamomum cassia, ripe fruits of Amomum kravanh, fruit clusters of Piperlonguml., flowers of Carthamus tinctorius, ripe fruits of Amomum tsao-ko, rhizomata of Zingiber officinale), etc. Principles of Mongolian medicine in treating diseases: by balancing “three essences or roots” and “seven elements”, strengthening liver and kidney function, transporting nutrients to enhance physical strength and disease resistance, and combined with drugs for comprehensive conditioning treatment. However, their molecular mechanisms remain unclear. In this review, we prospect that Mongolian medicines might be a promising treatment for T2DM-NAFLD by activating P2X7R/NLRP3/NF-κB inflammatory pathway via lipid-sensitive nuclear receptors (i.e., FXR and LXR).
    6  Sugemule-10: Source of prescription and modern clinical application
    Xiangmei Chen d e Liangliang a b Hadanbaoligao Zhang a Buriebao b c Xiulan Wang e WurihanTai b
    2022, 14(3).
    [Abstract](758) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Sugemule-10, one of the traditional Mongolian medicine (TMM) formulae, is derived from Four Medical Classics (Vol. 4) and composed of 10 Mongolian medicines. It is used to treat kidney cold, low back pain, urinary obstruction, kidney/bladder stones, and is the main prescription for kidney cold. The current research on Sugemule-10 is mostly focused on its clinical efficacy, and few papers are available upon its historical changes. Therefore, we systematically reviewed Sugemule-10 from the aspects of prescription source, prescription interpretation, efficacy evolution, and modern clinical applications.
    7  Famous traditional Mongolian medicine Xieriga?€?4 (Turmeric-4) Decoction: A review
    Dulan Bagenna Huan Wang Yuanyuan Wu Ling Ling Anggelima
    2022, 14(3).
    [Abstract](551) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Xieriga-4 Decoction, composed of dried rhizomes of Curcumae longae rhizoma, barks of Phellodendron chinense or Phellodendron amurense, fruits of Cardenia jasminoides, and fruits of Tribulus terrestris, is a famous prescription of traditional Mongolian medicine for the treatment of urinary system diseases such as frequent urination, urgent urination, urine occlusion, hematuria, bladder irritation and pain. This work reviewed Xieriga-4 Decoction from the aspects of historical description, prescription principle, chemical components, pharmacology, clinical application and quality control.
    8  Phytochemical and pharmacological progress on Syringa oblata, a traditional Mongolian medicine
    Badalahu Taia b Laxinamujila Baib Ruifeng Jic Muyao Yuc NAlab Luqi Huanga c Han Zhengc
    2022, 14(3).
    [Abstract](869) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Syringa oblata is a traditional Mongolian medicine mainly distributed in the Helan Mountains (the boundaries of Inner Mongolia and Ningxia, China) and the north of Yan Mountains (Aohan Qi, Inner Mongolia, China). It is clinically used to treat diseases caused by Heyi, such as heartache and heat pathogen in the heart. Phytochemical studies on S. oblata revealed the presence of iridoids, lignans, triterpenes, phenylpropanoids, phenylethanoids, and volatile components. Pharmacological investigations revealed a broad spectrum of bioactivities, such as antimicrobial, antioxidant, antiproliferative, and hepatoprotective effects. This article summarized the chemical components and pharmacological activities of S. oblata, providing a scientific rationale for its bioactive constituents, quality control, and utilization as an important medicine.
    9  Emerging therapeutic role of Prunella vulgaris in thyroid disease
    Wen Zhang a c Qimuge Wuhan c Meiri Na b Riba Hu b Qier Mu b Xilinqiqige Bao b c
    2022, 14(3).
    [Abstract](732) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Thyroid disease is characterized by unusual levels of thyroid hormones, which results in either hyperthyroidism or hypothyroidism. The pathology of a particular type or stage of thyroid disease is very complicated, and always linked to a variety of biological functions. Although the mortality rate is not high, thyroid dysfunction could leads to metabolic and immunological disorders that can subsequently cause discomfort. To date, many medical drugs are suggested to have curative effects on thyroid disease, however, drug toxicity and long treatment periods encourage the search for more promising drugs. Prunella vulgaris L. (Labiatae) is a popular herb that has shown great potential for improving human immunity and organ protection. It has been extensively used in the treatment of many diseases but its ability to treat specific diseases has not been fully reported. In this review, a literature search regarding herbs and herbal recipes for treating thyroid disease were carried out, organized, and summarized. In addition, this study conducted a literature search on the current situation and progress of P. vulgaris treatment for various diseases. Finally, this study discussed studies regarding P. vulgaris treatment of goiter, and the mechanism of treatment through the regulation of apoptosis. Accordingly, a combination therapy of herbs and Western medicine can provide significant therapeutic effects in the clinical treatment of thyroid disease. Furthermore, the association between P. vulgaris and various diseases suggests that P. vulgaris is rich in a variety of active substances that can fight oxidation and participate in the regulation of apoptosis, thus having a protective effect on the thyroid. Here, a comprehensive literature review regarding the application of herbs or herbal recipes in the treatment of thyroid disease was presented. It is concluded that there is strong evidence for further research regarding the use of P. vulgaris in the treatment of thyroid diseases.
    10  Metabolomics investigation on antiobesity effects of Corydalis bungeana on high-fat high-sugar diet-induced obese rats
    Minghai Fua b Terigele Baob Hongzhen Yub LiSha Aa HuiFang Lib Genna Bab Sungbo Choa b
    2022, 14(3).
    [Abstract](816) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective: Corydalis bungeana (CB) is a well-used medicinal herb in Mongolian folk medicine and has been traditionally applied?as?an antiobesity agent. However, the evidence-based pharmacological effects of CB and its specific metabolic alterations?in the obese model are not entirely understood. This study aimed to utilize untargeted metabolomic techniques to identify biomarkers and gain mechanistic insight into the serum metabolite alterations associated with weight loss and lipid metabolism in obese rats. Methods: A high-fat high-sugar (HFHS) diet was used to induce obese models in rats. CB extract was orally gavaged at 0.18, 0.9 and 1.8 g/kg doses for six weeks, and feed intake, body weight, fat pad weight, and blood indexes were measured. Blood serum metabolites were evaluated by gas chromatography/quadrupole time-of-flight tandem mass spectrometry (GC-TOF/MS). Results: The results showed that compared with the obese group, the administration of CB extract caused significant decreases in body weight (P < 0.05), feed intake, Lee’s index, and perirenal, mesenteric, epididymal fat weight. CB extract also reduced blood triglyceride and total cholesterol levels (P < 0.05) of obese rats. Metabolomic findings showed that nine differential metabolites, including pyruvic acid, D-glucuronic acid, malic acid, dimethylglycine, oxoglutaric acid, pantothenic acid, sorbitol acid, fumaric acid and glucose 6-phosphate were identified under CB treatment and altered metabolic pathways such as TCA cycle, pantothenate and CoA biosynthesis, and glycolysis/gluconeogenesis. Conclusion: This study demonstrated weight loss and lipid lowering effects of CB on HFHS diet-induced obese rats and identified nine metabolites as potential biomarkers for evaluating the favorable therapeutic mechanism of CB via regulation of lipid and glucose metabolism.
    11  Metabonomics study of liver and kidney subacute toxicity induced by garidi-5 in rats
    Wurihana b Aodungerleb Biligeb Lilib Sirgulengc Aduqinfud Meirong Bai a b
    2022, 14(3).
    [Abstract](823) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective Metabonomics was used to analyze and explore the biomarkers and possible mechanisms of liver and kidney subacute toxicity induced by garidi-5 in rats. Methods Taking garidi-5 as the target drug and SD rats as the research objects, each administration group except the normal group was intragastric administration of the corresponding drug solution for 28 d. The serum, liver and kidney samples of rats were detected by metabolomics and characterized by principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) to identify the sensitive markers and metabolic pathways of liver and kidney subacute toxicity. Results Metabolomics analysis showed that compared with the normal group (Z), the 52, 64 and 54 different metabolites were identified in the serum, liver and kidney samples of garidi-5 high dose group (GG), which were mainly enriched in ABC transporters, arginine and proline metabolism, nicotinate and nicotinamide metabolism, central carbon metabolism in cancer pathways. Conclusion The preliminarily suggested that garidi-5 can damage the liver and kidney by affecting the ABC transporters, arginine and proline metabolism, nicotinate and nicotinamide metabolism pathways, etc. Trimethylamine N-oxide, L-pyroglutamic acid, glycine-betaine, xanthine, glutathione, L-leucine, cytidine, L-arginine, spermidine, urea, 5-aminovaleric acid, creatine, L-glutamic acid, 1-methylnicotinamide and S-adenosyl-L-methionine can be used as potential biomarkers of liver and kidney toxicity sensitivity.
    12  Assessment of pulmonary infectious disease treatment with Mongolian medicine formulae based on data mining, network pharmacology and molecular docking
    Baochang Zhou a Zhanhong Qian a Qinyu Li b Yuan Gao c Minhui Li a b d e
    2022, 14(3).
    [Abstract](703) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective: Pulmonary infectious diseases (PID) include viral pneumonia (VP) and pulmonary tuberculosis (PT). Mongolian medicine (MM) is an effective treatment option in China, however, the core group medicines (CGMs) in the treatment of PID and their underlying therapeutic mechanisms remain unclear. In this study, through the method of data mining, the CGMs of MM for the treatment of PID were excavated, and the possible mechanism of action of the CGMs in the treatment of PID was explored by using network pharmacology. Methods: First, 89 MM formulae for the treatment of pulmonary infectious diseases collected from Gan Lu Si Bu, Meng Yi Jin Kui, People's Republic of China Ministry of Health Drug Standards (Mongolian Medicine Volume), Standard of Mongolian Medicine Preparations in Inner Mongolia (2007 Edition), and Standard of Mongolian Medicine Preparations in Inner Mongolia (2014 Edition). The CGMs of MM for PID were excavated through association rule analysis and cluster analysis. Then, the active ingredients and potential targets of the CGMs were obtained from TCMSP, TCMIP, BATMAN-TCM databases. PID targets information was collected from OMIM, GeneCards, and DrugBank databases. The possible targets of CGMs treatment for PID were obtained by intersection. The PPI network was constructed through the STRING database, and the topology analysis of the network was performed. Through the enrichment analysis of the intersection targets by R language, the main action pathways and related target proteins of CGMs in the treatment of PID were screened out. The results were verified by molecular docking. Results: A total of 89 formulae were included, involving 164 MM herbs. The efficacy of the drugs was mainly cough-suppressing and panting-calming herbs, and heat-clearing herbs. The nature and flavor were mainly bitter and cold. The CGMs of MM to treatment of PID was excavated as the classic famous formula Sanzi Decoction (Toosendan Fructus-Chebulae Fructus-Gardeniae Fructus). A total of 28 candidate components and 237 predicted targets of CGMs were collected, and 61 common targets with PID were obtained, including key compounds such as quercetin, kaempferol, β-sitosterol and stigmastero and key targets such as VEGFA, IL6, TP53, AKT1. KEGG enrichment analysis yielded AGE-RAGE signaling pathways, IL-17 signaling pathways, and TNF signaling pathways. Molecular docking results showed that the key targets were well matched with the potential active ingredients of CGMs. Conclusion: This study found that MM commonly used cough-suppressing and panting-calming herbs in combination with heat-clearing herbs to treat PID, and the CGMs for the treatment of PID is “Toosendan Fructus-Chebulae Fructus-Gardeniae Fructus”. CGMs mainly play a role in the treatment of PID by acting on VEGFA, IL6, TP53, AKT1 and other targets, regulating AGE-RAGE signaling pathways, IL-17 signaling pathways, and TNF signaling pathways.
    13  Tea and Citrus maxima complex induces apoptosis of human liver cancer cells via PI3K/AKT/mTOR pathway in vitro
    Shuai Wen Ran An Dong-li Li Jun-xi Cao Zhigang Li Wenji Zhang Ruohong Chen Qiuhua Li Xingfei Lai Lingli Sun Shili Sun
    2022, 14(3).
    [Abstract](881) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective In this study, black tea and Citrus maxima (BT-CM), yellow tea and C. maxima (YT-CM), green tea and C. maxima (GT-CM) as subjects, the active ingredient content and antioxidant activity of three tea and C. maxima (T-CM) were analyzed. The effects of three T-CMs on apoptosis of liver cells in vitro and its mechanism were further explored. Methods National standard method and HPLC were used for active ingredient analysis. MTT, cell flow cytometry and Western blot were used to analyze the effects of three T-CMs on cell proliferation, apoptosis, and its underlying molecular mechanism. Results The content of tea polyphenols, free amino acids, ratio of polyphenols and amino acids, ester catechins, non-ester catechins and caffeine in YT-CM and GT-CM was significantly higher than that of BT-CM. The in vitro antioxidant capacity of YT-CM and GT-CM was also significantly stronger than that of BT-CM. Three T-CMs had the effects of inhibiting proliferation, arresting cell cycle and inducing apoptosis in HepG2 and Bel7402 cells, especially YT-CM and GT-CM. Western blot analysis showed three T-CMs activated PI3K/AKT/mTOR signaling pathway and regulated the expression levels of apoptosis-related proteins Bax, Bcl-2 and Caspase-3/9. YT-CM and GT-CM had better ability to change the signal pathway than BT-CM. Conclusion In short, T-CMs, which combined different degrees of fermentation tea with C. maxima, were rich in nutrients and biologically active substances. T-CMs, especially YT-CM and GT-CM, are healthy drinks that help to prevent and treat liver cancer.
    14  Chemical constituents of Lomatogonium carinthiacum and Halenia corniculata
    Aodungerile a b Xigurigan b Tunumula b Gang Bao b Sudabilige b Chaogebadalafu b Chenlin He b Qirigeer a b Laxinamujila Bai a b Shuzhen Bai c
    2022, 14(3).
    [Abstract](831) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective: To study the chemical constituents from traditional characteristic Lomatogonium carinthiacum and Halenia corniculate. Methods: The chemical constituents were isolated and purified by silicagel column, Sephadex LH-20, ODS and high performance liquid chromategramphy. The structures were identified by NMR and MS analysis technics. Results: Twelve compounds were isolated and identified as isovitexin (1), Luteolin-5-O-β-D-glucoside (2), Isosaponarin (3), Luteolin-7-O-β-D-glucoside (4,7), 1,4,8-Trimethoxy-xanthone-6-O-β-D-glucoronyl-(1→6)O-β-Dglucoside (5), friginosideD (6), 1-hydroxy-2,3,5-trimethoxyxanthone (8), 1-hydroxy-2,3,4,5-tetramethoxyxanthone (9), 1-hydroxy-2,3,4,7-tetramethoxyxanthone(10), 1-hydroxy-2,3,4,5,7-pentamethoxyxanthone (11) and usnic acid (12). Conclusion: Compounds 6 and 12 are obtained from this medicine for the first time.
    15  Rapid quantitative analysis of 12 chemical constituents in wild-simulated and cultivated Astragali Radix based on UHPLC-MS
    Dan Li a b Yuetao Liu a b Xuemei Qin a b
    2022, 14(3).
    [Abstract](695) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective: Astragali Radix (AR) is one of the most widely used traditional Chinese medicines (TCMs) for tonic, which can be divided into wild-simulated and cultivated AR according to its cultivation method. However, whether cultivated AR can replace wild-simulated AR has always been a concern. Methods: In this study, a rapid, highly sensitive and specific analytical method using ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS) was developed to quantitatively measure 12 chemical constituents of AR in the different cultivation methods. Results: AR samples were analyzed with a good linear regression relationship (R2, 0.9983?0.9995), precisions (relative standard deviation (RSD), 1.31%?2.36%), repeatability (RSD, 2.65%?4.92%), stability (RSD, 1.50%?4.05%), and recovery (95.13%?106.52%). Through the determination of AR samples, we found the components of flavonoids in wild-simulated AR were higher than cultivated AR, the saponins in cultivated AR were higher, the ratio of saponins/flavonoids in cultivated AR was higher than wild-simulated AR. Conclusion: Based on this research, it could provide guidance for the quality control of AR.
    16  Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients: A retrospective cohort study
    Zhi-e Fanga b Yuming Guo a b Zhilei Wang a b Tingting He a b Jiabo Wang a b Zhaofang Bai a b Xiaohe Xiaoa b
    2022, 14(3).
    [Abstract](592) [HTML](0) [PDF 0.00 Byte](0)
    Abstract:
    Objective: Although some studies have linked Asari Radix et Rhizoma (Asari Radix) administration to hepatocellular carcinoma (HCC), few studies have examined the association between the development of HCC and the use of Asari Radix among patients in mainland China. This study aimed to evaluate the real-world association between Asari Radix and HCC in patients to strengthen the understanding of Asari Radix safety. Methods: A retrospective cohort study among hepatitis B?virus (HBV)-monoinfected patients and non-HBV-monoinfected patients were performed. Patients over 18 years of age were eligible for inclusion. Prescription records of inpatients and outpatients were inquired to distinguish Asari Radix users and nonusers. The risk of developing HCC among Asari Radix users and nonusers in the HBV cohort and the non-HBV cohort was analyzed. Results: There were 49 500 HBV and 133 148 non-HBV patients involved in the two cohorts. Among HBV patients (2 901 users; 46 599 nonusers), the prevalence of HCC in Asari Radix users was lower than that in nonusers (145.70 vs. 265.43 per 105). Among non-HBV patients (5 042 users; 128 106 nonusers), the prevalence of HCC in Asari Radix users was lower than that in nonusers (81.62 vs. 134.11 per 105). None of the hazard ratios (HRs) of Asari Radix exposure ranging from 1 g to 200 g in the two cohorts showed correlation between Asari Radix exposure and hepatocarcinogenesis. Conclusion: An obvious irrelevancy was found between the consumption of Asari Radix and HCC development both in patients with and in those without HBV infection. Use of Asari Radix under 200 g appears safe in terms of HCC risk in the Chinese population; further prospective studies are needed to confirm our results.

    Current Issue


    Volume , No.

    Table of Contents

    Archive

    Volume

    Issue

    Most Read

    Most Cited

    Most Downloaded

    WeChat

    Mobile website